title: Effect of surgery on gonadal function of premenopausal women with pituitary adenomas other than prolactinomas.
abstract: The effects of surgery on pituitary-gonadal function were investigated in women with pituitary adenomas other than prolactinomas. The subjects were 46 women of premenopausal age with a pituitary adenoma. Twenty tumors were GH producing, 19 were nonfunctioning, and 7 were adrenocorticotropin producing adenomas. The surgery was performed mainly via the transsphenoidal route, with the aim of eradicating the tumor and preserving pituitary function. The menstrual cycle was preserved postoperatively in 9 out of 10 (90%) patients with regular preoperative menstruation. Menstrual disturbance was seen in 36 (78.3%) cases preoperatively. The causative factors for menstrual disturbance were gonadotropin impairment and hyperprolactinemia in GH producing and nonfunctioning adenoma. Excessive hormonal secretion itself is a major causative factor for menstrual disturbance in GH and ACTH producing adenoma. Regular menstruation was restored following surgery in 20 out of 36 (55.6%) patients with menstrual problems. The predicting factors for postoperative recovery of menstruation are: size of adenoma less than 40 mm, period of amenorrhea less than 5 years, and preoperatively preserved gonadotropin secretion. In addition, preoperative hyperprolactinemia was also a predicting factor in women with nonfunctioning adenoma. Thus, even in patients with pituitary adenomas other than prolactinoma, the restoration of menstruation is highly achievable when surgery is performed with attention to preserving pituitary function.
authors.affiliation: Department of Neurosurgery, Hiroshima University School of Medicine, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Arita
authors.forename: T
authors.initials: T
authors.lastname: Uozumi
authors.forename: T
authors.initials: T
authors.lastname: Yano
authors.forename: K
authors.initials: K
authors.lastname: Kurisu
authors.forename: T
authors.initials: T
authors.lastname: Hirohata
authors.forename: K
authors.initials: K
authors.lastname: Eguchi
authors.forename: A
authors.initials: A
authors.lastname: Tominaga
authors.forename: B
authors.initials: B
authors.lastname: Pant
authors.forename: K
authors.initials: K
authors.lastname: Iida
authors.forename: H
authors.initials: H
authors.lastname: Kawamoto
mesh_terms: D000236:Adenoma / Q000378:metabolism / Q000503:physiopathology / Q000601:surgery*; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000096:biosynthesis; D000328:Adult; D002648:Child; D005260:Female; D019382:Human Growth Hormone / Q000096:biosynthesis; D006801:Humans; D008599:Menstruation Disturbances / Q000209:etiology / Q000628:therapy; D010053:Ovary / Q000503:physiopathology*; D010902:Pituitary Gland / Q000503:physiopathology*; D010908:Pituitary Hormones, Anterior / Q000378:metabolism; D010911:Pituitary Neoplasms / Q000378:metabolism / Q000503:physiopathology / Q000601:surgery*; D011247:Pregnancy
chemical_list: D010908:Pituitary Hormones, Anterior; D019382:Human Growth Hormone; D000324:Adrenocorticotropic Hormone